While the study showed data quality from places like India, Eastern Europe and Latin America is on-par with Canada and the U.S., the study isn't perfect, ACRO admits.
Valued at $49.4 million in terms of revenue in 2010 (a small but growing figure), the Argentine clinical trial market is forecast to grow at a compound annual growth rate of 9% between 2010 and 2015.
At the Pharmaceutical Contract Management Group (PCMG) annual conference this month, representatives from CROs and pharma companies sat down to discuss which industry was leading in innovation.
The multinational CRO announced that it will build its new regional headquarters in Shanghai and establish a partnership with the Shanghai Clinical Research Center (SCRC) to provide lab testing capabilities for local customers.
The global medical devices CRO market should grow at a compound annual growth rate (CAGR) of 12.5%, reaching around $7.4 billion by 2018, according to a new study from GlobalData.
The New Jersey CRO has teamed up with Bayer Healthcare in a deal that will see the two helping one another with R&D services.
The move reinforces the CRO's commitment to working in the country, despite controversy surrounding India's clinical and pharma handlings.
Synexus, a European recruitment and trial management firm, announced its acquisition of Polish CRO Osteomed.
ACRO India is casting doubt over a Pharmabiz article that claims efforts to video record clinical trials in the country was sprung by the umbrella organization, but in its response manages not to confirm or deny any involvement.
More than a week after testifying to the FDA on how it can improve its drug development and clinical trial regulations, ACRO wonders whether the FDA took its recommendations to heart.